LPS,from E. coli,297-473-0 |
|||||||
|
|
|
Cat.No.: |
IC-0225459 |
|
|
|
Product Information |
|||||||
Biological Activity |
|||||||
Lipopolysaccharides (LPSs) are characteristic components of the cell wall of Gram-negative bacteria. LPS and its lipid A moiety stimulate cells of the innate immune system by the Toll-like receptor 4 (TLR4), a member of the Toll-like receptor protein family, which recognizes common pathogen-associated molecular-patterns (PAMPs). |
|||||||
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines) |
|||||||
Species |
Mouse |
Rat |
Rabbit |
Guinea pig |
Hamster |
Dog |
|
Weight (kg) |
0.02 |
0.15 |
1.8 |
0.4 |
0.08 |
10 |
|
Body Surface Area (m2) |
0.007 |
0.025 |
0.15 |
0.05 |
0.02 |
0.5 |
|
Km factor |
3 |
6 |
12 |
8 |
5 |
20 |
|
Animal A (mg/kg) = Animal B (mg/kg) multiplied by (Animal B Km / Animal A Km) |
|||||||
Order Information |
|||||||
From Escherichia coli 055:B5 |
Quantity |
Price($£© |
Price(€) |
Price(£¤/CNY£© |
Price(£¤/JYP£© |
||
5mg |
$150.00 |
€180.00 |
£¤1,500.00 |
¥29,850.00 |
|||
25mg |
$420.00 |
€504.00 |
£¤4,200.00 |
¥83,580.00 |
|||
100mg |
$950.00 |
€1,140.00 |
£¤9,500.00 |
¥189,050.00 |
|||
|
Free Delivery on orders over $350.00. |
||||||
Chemical Information |
|||||||
Appearance (Form) |
Lyophilized Powder |
||||||
Application(s) |
Cell culture , Mammalian: suitable,TLR-4 activator |
||||||
CAS Number |
297-473-0 |
||||||
Purity |
N/A |
||||||
Solubility |
DMSO¡Ü14 mg/mL,H2O¡Ü5mg/ml |
||||||
Storage |
at -20¡ãC |
||||||
Reference |
|||||||
[1]. Kabanov DS, et al. Structural analysis of lipopolysaccharides from Gram-negative bacteria. Biochemistry (Mosc). 2010 Apr;75(4):383-404. |
|||||||
[2]. Heinrichs DE, et al. Molecular basis for structural diversity in the core regions of the lipopolysaccharides of Escherichia coli and Salmonella enterica. Mol Microbiol. 1998 Oct;30(2):221-32. |
|||||||
[3]. Cai KC, et al. Age and sex differences in immune response following LPS treatment in mice. Brain Behav Immun. 2016 Nov;58:327-337. |
|||||||
We Devoted Ourselves To The Development Of Biomedical Research Reagent. |
|||||||